Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer

Yongjian Yang, Dahai Qiu, Yajun Liu, Lei Chao Department of Anesthesiology, Jinan Central Hospital Affiliated to Shandong University, Ji’nan, Shandong Province 250013, People’s Republic of ChinaCorrespondence: Lei ChaoDepartment of Anesthesiology, Jinan Central Hospital Affiliate...

Full description

Bibliographic Details
Main Authors: Yang Y, Qiu D, Liu Y, Chao L
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/topical-anesthetic-analgesic-therapy-using-the-combination-of-ropivaca-peer-reviewed-article-DDDT
_version_ 1818217888149929984
author Yang Y
Qiu D
Liu Y
Chao L
author_facet Yang Y
Qiu D
Liu Y
Chao L
author_sort Yang Y
collection DOAJ
description Yongjian Yang, Dahai Qiu, Yajun Liu, Lei Chao Department of Anesthesiology, Jinan Central Hospital Affiliated to Shandong University, Ji’nan, Shandong Province 250013, People’s Republic of ChinaCorrespondence: Lei ChaoDepartment of Anesthesiology, Jinan Central Hospital Affiliated to Shandong University, No. 105 Jiefang Road, Ji’nan, Shandong Province 250013, People’s Republic of ChinaTel +86 05 318 569 5114Email leichaojncp@outlook.comPurpose: Hyaluronic acid-poly(ethylene glycol)-distearoyl phosphoethanolamine (HA-PEG-DSPE) modified and tocopheryl polyethylene glycol 1000 succinate (TPGS) contained nanostructured lipid carriers (NLCs) were prepared loading ropivacaine and dexmedetomidine to improve the topical anesthetic analgesic anesthesia efficiency.Methods: NLCs were prepared by the solvent diffusion method. The average particle size, zeta potential, release behavior, and cytotoxicity of the NLCs were tested. Ex vivo skin permeation was studied using a Franz diffusion cell mounted with depilated rat skin. Local anesthesia antinociceptive efficiency was evaluated by rat tail flick latency study in vivo.Results: NLCs have sizes of about 100 nm, with negative zeta potentials. All the NLCs formulations were found to be significantly less cytotoxic than free drugs at equivalent concentrations. The cumulative amount of drugs penetrated through rat skin from NLCs was 2.0–4.7 folds higher than that of the drugs solution. The in vivo anesthesia antinociception study displayed that NLCs showed stronger and longer anesthesia antinociceptive effect when compared with single drugs loaded NLCs and drugs solution even at a lower dosage of drugs.Conclusion: The results demonstrated that the HA modified, TPGS contained, dual drugs loaded NLCs could perform a synergistic effect and may reduce the amount of drugs, which can lower the toxicity of the system and at the meanwhile, increase the anesthesia antinociceptive efficiency.Keywords: topical anesthetic analgesic, skin penetration, hyaluronic acid, long-acting nanostructured lipid carriers, tocopheryl polyethylene glycol 1000 succinate
first_indexed 2024-12-12T07:15:01Z
format Article
id doaj.art-8b196e238a69452bb8dafd87ae9f9f6a
institution Directory Open Access Journal
issn 1177-8881
language English
last_indexed 2024-12-12T07:15:01Z
publishDate 2019-09-01
publisher Dove Medical Press
record_format Article
series Drug Design, Development and Therapy
spelling doaj.art-8b196e238a69452bb8dafd87ae9f9f6a2022-12-22T00:33:32ZengDove Medical PressDrug Design, Development and Therapy1177-88812019-09-01Volume 133307331948663Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancerYang YQiu DLiu YChao LYongjian Yang, Dahai Qiu, Yajun Liu, Lei Chao Department of Anesthesiology, Jinan Central Hospital Affiliated to Shandong University, Ji’nan, Shandong Province 250013, People’s Republic of ChinaCorrespondence: Lei ChaoDepartment of Anesthesiology, Jinan Central Hospital Affiliated to Shandong University, No. 105 Jiefang Road, Ji’nan, Shandong Province 250013, People’s Republic of ChinaTel +86 05 318 569 5114Email leichaojncp@outlook.comPurpose: Hyaluronic acid-poly(ethylene glycol)-distearoyl phosphoethanolamine (HA-PEG-DSPE) modified and tocopheryl polyethylene glycol 1000 succinate (TPGS) contained nanostructured lipid carriers (NLCs) were prepared loading ropivacaine and dexmedetomidine to improve the topical anesthetic analgesic anesthesia efficiency.Methods: NLCs were prepared by the solvent diffusion method. The average particle size, zeta potential, release behavior, and cytotoxicity of the NLCs were tested. Ex vivo skin permeation was studied using a Franz diffusion cell mounted with depilated rat skin. Local anesthesia antinociceptive efficiency was evaluated by rat tail flick latency study in vivo.Results: NLCs have sizes of about 100 nm, with negative zeta potentials. All the NLCs formulations were found to be significantly less cytotoxic than free drugs at equivalent concentrations. The cumulative amount of drugs penetrated through rat skin from NLCs was 2.0–4.7 folds higher than that of the drugs solution. The in vivo anesthesia antinociception study displayed that NLCs showed stronger and longer anesthesia antinociceptive effect when compared with single drugs loaded NLCs and drugs solution even at a lower dosage of drugs.Conclusion: The results demonstrated that the HA modified, TPGS contained, dual drugs loaded NLCs could perform a synergistic effect and may reduce the amount of drugs, which can lower the toxicity of the system and at the meanwhile, increase the anesthesia antinociceptive efficiency.Keywords: topical anesthetic analgesic, skin penetration, hyaluronic acid, long-acting nanostructured lipid carriers, tocopheryl polyethylene glycol 1000 succinatehttps://www.dovepress.com/topical-anesthetic-analgesic-therapy-using-the-combination-of-ropivaca-peer-reviewed-article-DDDTTopical anesthetic analgesicskin penetrationhyaluronic acidlong-acting nanostructured lipid carrierstocopheryl polyethylene glycol 1000 Succinate
spellingShingle Yang Y
Qiu D
Liu Y
Chao L
Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer
Drug Design, Development and Therapy
Topical anesthetic analgesic
skin penetration
hyaluronic acid
long-acting nanostructured lipid carriers
tocopheryl polyethylene glycol 1000 Succinate
title Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer
title_full Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer
title_fullStr Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer
title_full_unstemmed Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer
title_short Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer
title_sort topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine hyaluronic acid modified long acting nanostructured lipid carriers containing a skin penetration enhancer
topic Topical anesthetic analgesic
skin penetration
hyaluronic acid
long-acting nanostructured lipid carriers
tocopheryl polyethylene glycol 1000 Succinate
url https://www.dovepress.com/topical-anesthetic-analgesic-therapy-using-the-combination-of-ropivaca-peer-reviewed-article-DDDT
work_keys_str_mv AT yangy topicalanestheticanalgesictherapyusingthecombinationofropivacaineanddexmedetomidinehyaluronicacidmodifiedlongactingnanostructuredlipidcarrierscontainingaskinpenetrationenhancer
AT qiud topicalanestheticanalgesictherapyusingthecombinationofropivacaineanddexmedetomidinehyaluronicacidmodifiedlongactingnanostructuredlipidcarrierscontainingaskinpenetrationenhancer
AT liuy topicalanestheticanalgesictherapyusingthecombinationofropivacaineanddexmedetomidinehyaluronicacidmodifiedlongactingnanostructuredlipidcarrierscontainingaskinpenetrationenhancer
AT chaol topicalanestheticanalgesictherapyusingthecombinationofropivacaineanddexmedetomidinehyaluronicacidmodifiedlongactingnanostructuredlipidcarrierscontainingaskinpenetrationenhancer